Cerebrospinal fluid circulating tumor DNA depicts profiling of brain metastasis in NSCLC.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Dec 2022 – Sep 2023Where it's discussed
-
X / Twitter9 posts
-
Blogs2 articles
-
YouTube1 videos
AI synopsis
What people are saying
The analysis reveals a generally positive reception and high interest in the findings, with users highlighting the superior accuracy of cerebrospinal fluid ctDNA and its potential to improve profiling of brain metastases. The tone reflects enthusiasm and recognition of the study's potential clinical impact, as seen in phrases like 'superior to plasma ctDNA' and 'accurately representing profiling.' This demonstrates that the research is viewed as both innovative and impactful in the field.
Most discussions acknowledge the findings as valuable, with some emphasizing the superiority of cerebrospinal fluid ctDNA over plasma ctDNA for profiling brain metastases.
The posts demonstrate a high level of curiosity and enthusiasm about the research, reflecting strong engagement with the topic.
Several discussions delve into specifics, such as the methods used and the potential clinical implications, indicating active participation.
Many posts convey that this research could significantly influence diagnostic and treatment strategies for NSCLC brain metastases.
Top posts
Most liked on X and BlueskyResearch with Dr. Longbo Zhang @YNeurosurgery indicates cerebrospinal fluid circulating tumor DNA #ctDNA is superior to #plasma ctDNA in accurately representing the profiling of a single #brainmetastasis. #NSCLC @SmilowCancer https://t.co/B6PSZjhxXx @SmilowCancer @YaleMed @YNHH
RT @MolOncology:
FEBS Press https://t.co/JyORtrK3iX #lcsm
RT @MolOncology:
RT @MolOncology:
All mentions
Profiling Brain Metastasis in NSCLC Using Cerebrospinal Fluid ctDNA
This video explores how cerebrospinal fluid circulating tumor DNA enables profiling of brain metastases in non-small cell lung cancer, providing insights into tumor characterization through liquid biopsy techniques.
RT @MolOncology:
RT @MolOncology:
RT @MolOncology:
RT @MolOncology:
RT @MolOncology:
FEBS Press https://t.co/JyORtrK3iX #lcsm
Research with Dr. Longbo Zhang @YNeurosurgery indicates cerebrospinal fluid circulating tumor DNA #ctDNA is superior to #plasma ctDNA in accurately representing the profiling of a single #brainmetastasis. #NSCLC @SmilowCancer https://t.co/B6PSZjhxXx @SmilowCancer @YaleMed @YNHH
PubMed_ Cerebrospinal fluid circulating tumor DNA depicts profiling of brain metastasis in NSCLC https://t.co/HRWoVnXBBL